We are live on ! Find out more
WRF

Waddell & Reed Financial Portfolio holdings

AUM $48.6B
1-Year Est. Return 84.78%
This Fund
S&P 500
This Quarter Est. Return
+7.28%
1 Year Est. Return
+84.78%
3 Year Est. Return
+132.84%
5 Year Est. Return
+281.73%
10 Year Est. Return
AUM
$45.1B
AUM Growth
+$94.6M
Cap. Flow
-$2.51B
Cap. Flow %
-5.57%
Top 10 Hldgs %
18.78%
Holding
580
New
61
Increased
167
Reduced
261
Closed
54

Sector Composition

Rank Sector Weight
1 Technology 24.47%
2 Financials 14.41%
3 Consumer Discretionary 11.87%
4 Healthcare 11.47%
5 Industrials 10.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MKTX icon
176
MarketAxess Holdings
MKTX
$5.72B
$64M 0.14%
317,105
+48,623
+18% +$9.17M
SU icon
177
Suncor Energy
SU
$70.3B
$63.6M 0.14%
1,732,803
-18,475
-1% -$642K
BAH icon
178
Booz Allen Hamilton
BAH
$9.15B
$63.6M 0.14%
1,667,730
-25,910
-2% -$980K
BEST
179
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
$62.9M 0.14%
350,000
WSM icon
180
Williams-Sonoma
WSM
$29.6B
$62.8M 0.14%
2,430,056
-653,306
-21% -$16.7M
SYF icon
181
Synchrony
SYF
$25.6B
$62.3M 0.14%
1,613,700
-428,300
-21% -$14.7M
TS icon
182
Tenaris
TS
$26.8B
$62.2M 0.14%
1,952,200
+754,300
+63% +$21.8M
KSU
183
DELISTED
Kansas City Southern
KSU
$61.3M 0.14%
582,233
+452,188
+348% +$48.2M
AGNC icon
184
AGNC Investment
AGNC
$12.9B
$61.1M 0.14%
3,024,300
+534,500
+21% +$11M
MPC icon
185
Marathon Petroleum
MPC
$83.7B
$60.5M 0.13%
916,658
-265,821
-22% -$16.3M
DY icon
186
Dycom Industries
DY
$12.3B
$59.9M 0.13%
537,980
-8,490
-2% -$819K
TDOC icon
187
Teladoc Health
TDOC
$1.3B
$58.4M 0.13%
1,674,761
+261,530
+19% +$8.68M
RSPP
188
DELISTED
RSP Permian, Inc.
RSPP
$58.1M 0.13%
1,429,154
+242,291
+20% +$8.7M
ABMD
189
DELISTED
Abiomed Inc
ABMD
$57.2M 0.13%
305,334
+131,120
+75% +$24.5M
CLB icon
190
Core Laboratories
CLB
$521M
$57.1M 0.13%
521,365
+199,914
+62% +$20M
RDS.A
191
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$55.5M 0.12%
831,424
-139,392
-14% -$8.79M
AMGN icon
192
Amgen
AMGN
$222B
$55.3M 0.12%
318,134
+16,100
+5% +$2.85M
ECL icon
193
Ecolab
ECL
$79.9B
$54.9M 0.12%
409,518
+352,318
+616% +$46.9M
IBP icon
194
Installed Building Products
IBP
$6.49B
$54.7M 0.12%
720,814
-10,890
-1% -$754K
BURL icon
195
Burlington
BURL
$23.2B
$54.6M 0.12%
443,430
-6,980
-2% -$711K
CTSH icon
196
Cognizant
CTSH
$26B
$54.3M 0.12%
764,906
+25,478
+3% +$1.86M
BKR icon
197
Baker Hughes
BKR
$61.1B
$54.2M 0.12%
1,711,548
+8,860
+0.5% +$284K
EXC icon
198
Exelon
EXC
$47B
$54.1M 0.12%
1,924,946
-12,758
-0.7% -$367K
JBTM
199
JBT Marel
JBTM
$6.39B
$53.8M 0.12%
485,500
-7,440
-2% -$813K
CVS icon
200
CVS Health
CVS
$122B
$53.1M 0.12%
732,969
-424,366
-37% -$30.9M

Similar funds

Waddell & Reed Financial's Q4 2017 Portfolio in Review

As of Q4 2017, Waddell & Reed Financial held 580 positions worth $45.1B, up 0.21% from $45B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Waddell & Reed Financial withdrew a net $2.51B in Q4 2017, closing 54 positions and reducing 261 holdings. Its most notable exit was Kite Pharma, Inc., an estimated $171M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Waddell & Reed Financial opened a new position in TE Connectivity worth $93.5M.

  • Waddell & Reed Financial's largest Q4 2017 buy was TE Connectivity: 983,623 shares worth $93.5M.
  • Waddell & Reed Financial added most to UnitedHealth in Q4 2017, an estimated $138M increase.
  • Waddell & Reed Financial's biggest Q4 2017 reduction was Philip Morris, cutting an estimated $219M.
  • Waddell & Reed Financial fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $171M.
  • Waddell & Reed Financial's ten largest holdings make up 19% of its $45.1B portfolio in Q4 2017.
  • Waddell & Reed Financial opened 61 new positions and closed 54 in Q4 2017.
  • Waddell & Reed Financial's portfolio value rose 0.21% quarter-over-quarter to $45.1B.

Based on Waddell & Reed Financial's 13F filing for Q4 2017, filed 14 Feb 2018.